Home
Choose language  
Pharmacoreport Pharmacoreport
www.pharmacoreport .com is a news site providing information about the top international pharmaceutical companies. This website will also provide other information about these pharmaceuticals like their address and locations, corporate history, clinical trials, annual report, employees, careers and jobs, health care products, research, sales, shares, dividend & stock price, and patients’ assistance program.
 
Sanofi-Aventis   Sanofi-Aventis

 


Sanofi-Aventis has secured and maintained the position amongst the five biggest pharmaceuticals companies of the world that also include pharmaceutical giants like Pfizer, Bristol-Myer Squibb, Novartis and GlaxoSmithKline. The company is having it’s headquarter located in Paris, France and is engaged in consistent researching, developing, producing and commercializing of the different pharmaceutical products mainly in the prescription market segments. Moreover, the company also offers several products for sale under the OTC segments. Sanofi-Aventis including its subsidiary Sanofi-Pasteur has included 7 essential therapeutic sectors such as: cardiovascular, thrombosis, oncology, diabetes, central nervous system-CNS, internal medications and different vaccines.    

The entity of Sanofi-Aventis was constituted sometimes during 2004 following Sanofi-Synthelabo duly amalgamated with Aventis when it made the aggressive takeover bid worth € 47.8 billion against Aventis. Sanofi-Synthelabo was formed in 1999 when Sanofi [which was the subsidiary of Total, earlier] amalgamated with Synthelabo [former subsidiary of L’Oreal] and this amalgamated company was located in Paris, France. 
                                                                                                  
Aventis was shaped up during 1999 when Rhone-Poulenc S.A. amalgamated with Hoechst Marion Roussel which was constituted following the unification of Hoechst AG and Roussel Uclaf and Marion Merrell Dow. This new unified company was situated at Schiltigheim, near Strasbourg in France.

Sanofi-Aventis offers different medications for the treating the patients of several therapeutic sectors like: cardiovascular ailments, thrombosis related ailments, metabolic disorders, oncology diseases, central nervous system-CNS related disorders, several internal medications and different types of vaccines for preventing various diseases.

Some of the major and popular products of this company include: Lasix, Amaryl, Taxotere, Allegra, Rabipur, Frisium, Plavix, Cordarone, Stilnoct, Primacor IV, Valparin and Myoril.



Chiren Corporation , Nowo Nordisk , Amgemn , Solvey , Alergan , Whyeth , Elcon , Bohringer Ingelheim , Shienogi and Co , Senkyo Co
Latest News About sanofi-aventis
Sanofi-Aventis said to be mystery ImClone suitor - report
LONDON (AFX) - Sanofi-Aventis the secret announcement participant in last months is has nominally tried acceptance of USA biotechnology firm ImClone systems Inc, .....More
Sanofi-Aventis could buy biotech co if appropriate one available -...
PARIS (AFX) - a biotechnology firm could not buy Sanofi-Aventis if there was an available with three or four products, something, that momentarily that is, .....More
Lawyer urges halt to generic of Plavix
NEW YORK a lawyer for Bristol-Myers Squibb and Sanofi-Aventis judge told on Friday AN USA that the introduction of a generic version of its box-office hit drug.....More
Sanofi-Aventis loses US patent case
French pharmaceutical firm Sanofi-Aventis SOWED said Friday, lost was that it an USA court. hat. the attempt whether Sanofi-Aventis to determine, that is named busied with so, .....More
Super pill may also fight drug, alcohol abuse - Fitness - MSNBC.com
Feb. 6: TODAY diet and nourishment editor Madelyn distance current speeches with TODAYand Natalie moral approximately calcium, and like it with weight loss,. kann. help...More
Pfizer to Pay Sanofi-Aventis $1.3 Billion
(AP) Pfizer inc. said Thursday that it becomes Sanofi-Aventis group $1.3 of billion paying to received full rights to the inhaled insulins the firms developed collective, .....More
Fighting flu: fears of a global pandemic prod the vaccine makers to...
While international matter are awake around the expansion of bird flu, researchers will gather to discuss at the world health organization in Geneva of this week.....More
Sanofi& Worldwide Serial Dramas
Sanofi-Aventis (SNY - commentary - Cramerand taking) becomes king of the pharmaceutical tension series while it seems, that each business stressful with tension ist...More
10-Q: IMMUNOGEN INC
(EDGAR Online over COMTEX) -- THING 2nd Managementand discussion and analysis of financial condition and results of the businesses since the Companyand start, .....More
Sanofi-Aventis, Pfizer say studies demonstrate Exubera effectiveness
PARIS (AFX) - Sanofi-Aventis SOWED and said Pfizer Inc results of three two year-old studies of its collective developed Exubera insulin treatment shown.....More

Enquiry

 Field Marked with asterisk (*) are mandatory

Name * Email *
State/Country

      

Comments *